Navigation Links
Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
Date:3/2/2009

BOTHELL, Wash., March 2 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will release its fourth quarter 2008 financial results on Thursday, March 12, 2009 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the fourth quarter as well as the current business outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To access the conference call, please dial 800-257-3401. International participants can dial 303-262-2125. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11125955#. An archived webcast will also be available at www.cardiacscience.com for 90 days.

    For more information,
    Company Contact:               Investor Contact:        Media Contact:
    Mike Matysik                   Doug Sherk               Christopher Gale
    Cardiac Science Corporation    Jenifer Kirtland         EVC Group, Inc.
    Sr. Vice President and CFO     EVC Group, Inc.          (646) 201-5431
    (425) 402-2009                 (415) 896-6820           (203) 570-4681
                                                            cgale@evcgroup.com

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit www.cardiacscience.com.

CSCX-F


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
2. Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference
3. Sudden Cardiac Death Rare in Young Athletes
4. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
5. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
6. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
7. iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies
8. Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
9. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
10. Experts Urge Limits on Use of Cardiac CT Scans
11. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: